The average discounted lifetime costs were $237 177 Canadian dollars for Andexanet and $177 871 Canadian dollars for PCC. PCC had a discounted life expectancy of 2.09 years and a discounted QALY of 1.28.
Andexanet had the highest discounted life expectancy of 2.53 years and a discounted QALY of 1.55. Customer Service and Ordering InformationĪn overall reduction in fatal ICrH and increase in thromboembolic events was associated with Andexanet compared with PCC.Stroke: Vascular and Interventional Neurology.Journal of the American Heart Association (JAHA).
0 kommentar(er)
